ArticleAmerican journal of translational research2025
Effects of hysteroscopic cold knife technique on the treatment of endometrial polyps and its protective effect on the endometrium.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore the effects of hysteroscopic cold knife technology in the treatment of endometrial polyps and its protective effect on the endometrium.
methodsThis retrospective study included 106 patients with endometrial polyps admitted to Jiashan County Second People's Hospital between January 2019 and August 2023. The patients were divided into an observation group and a control group based on their treatment model, with 53 cases in each. The control group was treated with hysteroscopic electrosurgery, and the observation group was treated with hysteroscopic cold knife technology. Perioperative conditions, inflammatory factor levels (C-reactive protein (CRP), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6)), uterine artery resistance index (RI), pulsatility index (PI), endometrial thickness, estrogen receptor (ER) and progesterone receptor (PR) levels, the incidences of postoperative complications, and recurrence rates were compared between the two groups.
resultsIn the observation group, the operation time, intraoperative blood loss, postoperative vaginal bleeding duration, postoperative vaginal bleeding volume, hospital stays and hospital costs were (20.87±3.02) min, (19.84±2.63) mL, (2.45±0.38) d, (2.69±0.53) mL, (4.57±0.85) d, and (719.54±78.23) dollars, respectively, all of which were significantly lower than those in the control group (all P<0.001). At 1 month postoperatively, serum CRP, TNF-α, and IL-6 levels in the observation group were (4.21±0.32) mg/L, (45.04±4.62) ng/L, and (64.38±5.29) pg/m/L, respectively, all significantly lower than those in the control group (all P<0.001). At 3 months postoperatively, the RI, PI and endometrial thickness in the observation group were (0.68±0.13), (0.84±0.16), and (5.59±0.73) mm, respectively, all significantly lower than those in the control group (all P<0.001). At 3 months postoperatively, ER and PR were (1.68±0.21) U/L and (0.97±0.19) U/L in the observation group, respectively, which were lower than those in the control group. No statistically significant differences in complication rates were observed between the two groups. The recurrence rate in the observation group was 3.77%, which was lower than that in the control group.
conclusionHysteroscopic cold knife technology is an effective and minimally invasive treatment for endometrial polyps, with rapid postoperative recovery and protective effects on the endometrium.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.